外体治疗是再生医学的奢领域
Nahla A Hassaan1, Hanaa A Mansour2
1Department of Zoology, Faculty of Science, Al-Azhar University, Cairo, Egypt.
Tissue & cell
|October 9, 2024
概括
来自干细胞的外体提供了一个有前途的无细胞疗法用于组织再生,克服了传统细胞移植的局限性. 这些纳米级囊泡提供治疗分子,有助于治疗各种疾病.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 干细胞疗法在组织再生方面表现有前途,但面临诸如免疫排斥和细胞存活率低下等挑战.
- 这些局限性阻碍了基于干细胞的再生策略的临床转化.
- 干细胞分泌的外体细胞正在成为强大的治疗药物.
研究的目的:
- 审查介质干细胞 (MSC) 衍生的外生体的治疗潜力.
- 讨论外体生物发生,分离方法,以及它们在无细胞疗法中的应用.
- 突出MSC衍生的外体作为治疗各种疾病的可行替代方案.
主要方法:
- 关于干细胞衍生外体的研究的文献综述.
- 对外体生物发生和货物转移机制的分析.
- 在临床前模型中对治疗应用的评估.
主要成果:
- 外基因组作为关键的膜介质,转移功能分子,如miRNAs和蛋白质.
- 只有MSC衍生的外体才能复制MSCs的治疗效果.
- 这些外体显示出治疗神经,免疫和心脏病的潜力.
结论:
- 来自MSC的外体体代表了无细胞再生医学的重大进步.
- 它们传递治疗有效载荷的能力为治疗各种疾病提供了一个多功能平台.
- 对外体生物发生和分离的进一步研究对于临床发展至关重要.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Embryonic Stem Cells
26.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
26.4K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K


